Related Experiment Video
Updated: Sep 9, 2025
06:34
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.1K
Pollen-induced asthma: diagnostic and therapeutic implications
L Cecchi1, A Musarra2, K Jaubashi3
1Allergy and Immunology Unit, San Giovanni di Dio Hospital, USL Toscana Centro, Florence, Italy.
European Annals of Allergy and Clinical Immunology
|September 2, 2025
Summary
Pollen-induced asthma is a distinct phenotype. A new diagnostic scheme and risk-stratified treatment algorithm are proposed for managing pollen allergy asthma effectively.
Area of Science:
- Allergy and Immunology
- Respiratory Medicine
- Clinical Medicine
Background:
- Pollen-induced asthma is recognized as a specific asthma phenotype with unique clinical characteristics.
- Diagnosis and symptom severity fluctuate significantly between pollen seasons and asymptomatic periods.
- Pollen exposure is a primary trigger for asthma symptoms and exacerbations.
Purpose of the Study:
- To introduce a novel diagnostic scheme for pollen-induced asthma.
- To develop a risk stratification model for tailored therapeutic strategies.
- To provide an evidence-based therapeutic algorithm for managing pollen-induced asthma.
Main Methods:
- Development of a novel diagnostic scheme for pollen-induced asthma.
- Implementation of a risk stratification model incorporating patient history and objective markers.
- Proposal of a therapeutic algorithm based on risk assessment.
Main Results:
- A new diagnostic approach for pollen-induced asthma has been established.
- A risk stratification model enables personalized treatment selection.
- The proposed algorithm facilitates tailored management strategies.
Conclusions:
- Pollen-induced asthma requires specific diagnostic and management approaches.
- Risk stratification is crucial for optimizing therapeutic interventions.
- The developed scheme and algorithm support personalized care for pollen-induced asthma patients.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
575
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
575